Otsuka confirms takeover bid for Astex Pharmaceuticals for $886 million


Following heavy speculation on Wednesday (see The Pharma Letter story earlier today), this morning Japanese…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Otsuka said to be buying Astex Pharma


Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

EU approval for Janssen-Cilag's Dacogen and Novartis/Vectura's Seebri Breezhealer


The European Commission on Friday approved the marketing authorization for Janssen-Cilag's (a unit of…

Astex PharmaceuticalsDacogenEuropeJanssen-CilagJohnson & JohnsonNovartisOncologyPharmaceuticalRegulationRespiratory and PulmonarySeebri BreezhalerVectura

Astex Pharma shares down after company drops amuvatinib development


US drug developer Astex Pharmaceuticals (Nasdaq: ASTX) saw its shares fall 8.1% to $3.05 by close last…

amuvatinibAstex PharmaceuticalsBiotechnologyLicensingOncologyPharmaceuticalResearch

US FDA delays Eisai's Dacogen for AML; accepts perampanel NDA


The US Food and Drug Administration has issued a Complete Response Letter to Japanese drug major Eisai…

Astex PharmaceuticalsDacogenEisaiNeurologicalNorth AmericaOncologyperampanelPharmaceuticalRegulation

FDA wants more info on Menveo; advisory negative on Dacogen


Swiss drug major Novartis (NOVN: VX) said this morning that it has received a Complete Response letter…

Astex PharmaceuticalsDacogenEisaiMenveoNorth AmericaNovartisOncologyPharmaceuticalRegulationVaccines

Astex to return epigenetics project to GSK


Astex Pharmaceuticals (Nasdaq: ASTX) says that the multi-year collaboration to discover cancer therapeutics…

Astex PharmaceuticalsGlaxoSmithKlineLicensingOncologyPharmaceuticalSuperGen

Astex Thera to merge into SuperGen in cash and stock deal


USA-based cancer drug developer SuperGen (Nasdaq: SUPG) and privately-held UK biotech firm Astex Therapeutics…

Astex PharmaceuticalsAstex TherapeuticsBiotechnologyMergers & AcquisitionsOncologyPharmaceuticalSuperGen

Back to top